Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Overview of Cell-Matrix Interactions01:24

Overview of Cell-Matrix Interactions

The extracellular matrix or ECM holds cells together to form a tissue and allows the cells within the tissue to communicate. ECM comprises proteins such as fibronectin, collagen, laminin, etc. The most abundant protein in this space is collagen. Collagen fibers are interwoven with carbohydrate-containing protein molecules called proteoglycans. ECM allows cell migration and provides a structural scaffold at cell adhesion that anchors the cell when the extracellular matrix proteins interact with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy.

Cell reports. Medicine·2026
Same author

Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor Therapy.

bioRxiv : the preprint server for biology·2026
Same author

Dissection of Gαs and Hedgehog Signaling Cross-talk Reveals Therapeutic Opportunities to Target Hedgehog-Dependent Tumors.

Cancer research·2025
Same author

ANTXR1 blockade enhances cardiac function in preclinical models of heart failure.

Nature cardiovascular research·2025
Same author

m276-SL-PBD eradicates tumors and instigates long-lasting tumor-free survival in Merkel cell carcinoma preclinical models.

iScience·2025
Same author

Dissection of Gαs and Hedgehog signaling crosstalk reveals therapeutic opportunities to target adenosine receptor 2b in Hedgehog-dependent tumors.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Jul 14, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Genes that distinguish physiological and pathological angiogenesis.

Steven Seaman1, Janine Stevens, Mi Young Yang

  • 1Tumor Angiogenesis Section, Mouse Cancer Genetics Program, National Cancer Institute at Frederick, Frederick, MD 21702, USA.

Cancer Cell
|June 15, 2007
PubMed
Summary

Researchers compared gene expression in normal and tumor blood vessels. Tumor blood vessels show unique gene expression patterns, suggesting new targets for cancer therapies.

More Related Videos

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay
09:16

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay

Published on: May 31, 2024

Related Experiment Videos

Last Updated: Jul 14, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay
09:16

Investigating Angiogenesis on a Functional and Molecular Level by Leveraging the Scratch Wound Migration Assay and the Spheroid Sprouting Assay

Published on: May 31, 2024

Area of Science:

  • Vascular biology
  • Cancer research
  • Transcriptomics

Background:

  • Understanding the normal blood vessel transcriptome is crucial.
  • Malignant cells can alter the tumor microenvironment, including vasculature.

Purpose of the Study:

  • To characterize the normal vasculature transcriptome.
  • To identify gene expression differences in tumor endothelium compared to normal and regenerating endothelium.
  • To explore potential targets for tumor-specific therapies.

Main Methods:

  • Comparative gene expression analysis of endothelial cells.
  • Samples from normal tissues, tumors, and regenerating liver were used.
  • Transcriptome profiling was performed.

Main Results:

  • Organ-specific endothelial genes were identified, with 27 unique to brain vasculature.
  • 25 transcripts were overexpressed in tumor endothelium versus normal endothelium.
  • 13 of these tumor-specific transcripts were not found in regenerating liver vasculature.

Conclusions:

  • Tumor vasculature exhibits distinct gene expression profiles compared to normal and physiologically angiogenic vasculature.
  • Tumor-specific transcripts include cell surface molecules with unknown functions.
  • These findings highlight differences between physiological and pathological angiogenesis, offering potential for targeted cancer therapies.